You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 165 No. 16, September 12, 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (29)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Genetics
 •Genetic Disorders
 •Osteoporosis
 •Aging/ Geriatrics
 •Alert me on articles by topic

Genetic Liability to Fractures in the Elderly

Karl Michaëlsson, MD, PhD; Håkan Melhus, MD, PhD; Helene Ferm, MD; Anders Ahlbom, PhD; Nancy L. Pedersen, PhD

Arch Intern Med. 2005;165:1825-1830.

Background  The genetic impact on the causation of osteoporotic fractures is unclear. A large twin study is ideally suited to determine the genetic liability to categories of fracture at various ages.

Methods  A cohort of all 33 432 Swedish twins born from 1896 to 1944 was used to evaluate the genetic liability to fracture occurrence in the elderly. The Swedish Inpatient Registry and computer-assisted telephone interviews enabled us to identify 6021 twins with any fracture, 3599 with an osteoporotic fracture, and 1055 with a hip fracture after the age of 50 years.

Results  Genetic variation in liability to fracture differed considerably by type of fracture and age. Less than 20% of the overall age-adjusted fracture variance was explained by genetic variation. The age-adjusted heritability of any osteoporotic fracture was slightly greater (0.27; 95% confidence interval [CI], 0.09-0.28), and for hip fracture alone, it was 0.48 (95% CI, 0.28-0.57). Heritability was not attenuated after further adjustment for several known osteoporotic covariates but was considerably greater for first hip fractures before the age of 69 years (0.68; 95% CI, 0.41-0.78) and between 69 and 79 years (0.47; 95% CI, 0.04-0.62) than for hip fractures after 79 years of age (0.03; 95% CI, 0.00-0.26).

Conclusions  The importance of genetic factors in propensity to fractures depends on fracture site and age. The search for susceptibility genes and environmental factors that may modulate expression of these genes in younger elderly patients with hip fracture, the most devastating osteoporotic fracture, should be encouraged. Prevention of fractures in the oldest elderly should focus on lifestyle interventions.


Author Affiliations: Departments of Surgical Sciences (Drs Michaëlsson and Ferm) and Medical Pharmacology (Dr Melhus), Uppsala University Hospital, Uppsala, Sweden; and Departments of Environmental Medicine (Dr Ahlbom) and Medical Epidemiology and Biostatistics (Dr Pedersen), Karolinska Institute, Stockholm, Sweden.


RELATED ARTICLES

Practicing Medicine at the Front Lines of the Genomic Revolution
Wendy S. Rubinstein and Hemant K. Roy
Arch Intern Med. 2005;165(16):1815-1817.
EXTRACT | FULL TEXT  

Prediction of Progression to Cirrhosis by a Glutathione S-Transferase P1 Polymorphism in Subjects With Hereditary Hemochromatosis
Felix Stickel, Christoph H. Österreicher, Christian Datz, Peter Ferenci, Marco Wölfel, Wolfgang Norgauer, Michael R. Kraus, Fritz Wrba, Claus Hellerbrand, and Detlef Schuppan
Arch Intern Med. 2005;165(16):1835-1840.
ABSTRACT | FULL TEXT  

Ready for Genomic Medicine? Perspectives of Health Care Decision Makers
Paul R. Billings, Rick J. Carlson, Josh Carlson, Mary Cain, Charles Wilson, Peter Shorett, and Wendy Everett
Arch Intern Med. 2005;165(16):1917-1919.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Genetics of Osteoporosis: From Population Association to Individualized Prognosis of Fracture
Nguyen
IBMS BoneKEy 2008;5:212-221.
FULL TEXT  

Osteoprotegerin Lys3Asn Polymorphism and the Risk of Fracture in Older Women
Moffett et al.
J. Clin. Endocrinol. Metab. 2008;93:2002-2008.
ABSTRACT | FULL TEXT  

The Impact of Estradiol on Bone Mineral Density Is Modulated by the Specific Estrogen Receptor-{alpha} Cofactor Retinoblastoma-Interacting Zinc Finger Protein-1 Insertion/Deletion Polymorphism
Grundberg et al.
J. Clin. Endocrinol. Metab. 2007;92:2300-2306.
ABSTRACT | FULL TEXT  

Identification of an Aromatase Haplotype That Is Associated with Gene Expression and Postmenopausal Osteoporosis
Riancho et al.
J. Clin. Endocrinol. Metab. 2007;92:660-665.
ABSTRACT | FULL TEXT  

Adiposity, estradiol, and genetic variants of steroid-metabolizing enzymes as determinants of bone mineral density
Zarrabeitia et al.
Eur J Endocrinol 2007;156:117-122.
ABSTRACT | FULL TEXT  

Genetic regulation of bone mass and susceptibility to osteoporosis
Ralston and de Crombrugghe
Genes Dev. 2006;20:2492-2506.
ABSTRACT | FULL TEXT  

Clinical and Basic Research Papers - October 2005 Selections
Ferrari et al.
IBMS BoneKEy 2005;2:1-6.
FULL TEXT  

Practicing Medicine at the Front Lines of the Genomic Revolution
Rubinstein and Roy
Arch Intern Med 2005;165:1815-1817.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.